Back to search

Netherlands· NL-1e6f66f887b1

Buprenorfine G.L. Pharma 0,2 mg tabletten voor sublinguaal gebruik

A buprenorphine product containing buprenorfinehydrochloride, registered in Netherlands by G.L. Pharma GmbH. The same ATC class is registered in 13 of our 19 countries.

ATC N02AE01

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedBuprenorfine G.L. Pharma 0,2 mg table…ATCN02AE01REGISTER NO.NL-1e6f66f887b1PACKS LISTED1CHECKEDSeptember 29, 2026

Where it is registered

Buprenorphine is registered in 13 of 19 countries.

Countries holding a registration under ATC N02AE01 (buprenorphine), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 8 of them publish a price we can compare per daily dose

Buprenorphine · ATC N02AE01

13 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of buprenorphine costs, country by country.

Normalised to the WHO defined daily dose (1.2 mg), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Buprenorphine · price per daily dose (1.2 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$0.77
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)
Active substance
BUPRENORFINEHYDROCHLORIDE
Manufacturer
G.L. Pharma GmbH
Country
Netherlands (NL)
ATC code
N02AE01
ATC class
Buprenorphine
Defined daily dose
1.2 mg, P
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    132208

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

378 interactions on record for buprenorphine.

Graded by severity as the source publishes them — 59 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Buprenorphine · interactions on record

378 records

  • 59 severe
  • 253 moderate
  • 2 minor
  • 52 info

Most severe, free to view

  • PapaverineA03AD01severe
  • CisaprideA03FA02severe
  • DolasetronA04AA04severe
  • DronabinolA04AD10severe

12 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Buprenorphine in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All buprenorphine products

Authorised across Europe · EMA

The same active substance is authorised in 27 EEA countries. Names it is sold under:

  • Austria · Astec, Bupensan
  • Belgium · Temgesic, Transtec
  • Bulgaria · Бупренорфин G.L., Бупренорфин Актавис
  • Cyprus · Buvera
  • Czechia · Addnok, Buprenorfin Stada
  • Germany · Acimaphin, Acinorphin
  • Denmark · Buprefarm, Bupremyl
  • Estonia · Buprenorphine G.L. Pharma
  • Spain · Buprenorfina Andrómaco, Buprenorfina Sandoz
  • Finland · Buprefarm, Bupremyl
  • France · Bupensan, Buprenorphine Arrow
  • United Kingdom (Northern Ireland) · Addnok, Bunov
  • Greece · Buprenal, Buvera
  • Croatia · Buprenorfin Alkaloid, Buprenorfin Sandoz
  • Ireland · Buprenorphine Activase Pharmaceuticals, Buprenorphine Morningside Healthcare
  • Iceland · Buprenorphine Alvogen, Buprenorphine Neuraxpharm
  • Italy · Buprenorfina Molteni, Buprenorfina Sandoz
  • Liechtenstein · Buprenorphine Neuraxpharm, Buvidal
  • Luxembourg · Temgesic, Temgesic Sublingualis
  • Latvia · Buprenorphine G.L. Pharma
  • Malta · Buprenorphine Aspire Pharma (Malta), Natzon
  • Norway · Bugnanto, Buprefarm
  • Poland · Bunondol, Bunorfin
  • Portugal · Buprenorfina, Buprenorfina Aurovitas
  • Sweden · Buprefarm, Buprenorfin Actavis
  • Slovenia · Addnok, Buprenorfin Alkaloid-Int
  • Slovakia · Bupretec, Noprex

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/0acd6bc0-4afe-44b2-8b2e-63fa582ec1db
GET /v1/drugs/0acd6bc0-4afe-44b2-8b2e-63fa582ec1db?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tablet",
  "route": "Sublinguaal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h132208_smpc.pdf",
  "strength": null,
  "atc_label": "Buprenorphine",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg132208",
  "excipients": [
    "CITROENZUUR 1-WATER (E 330)",
    "LACTOSE 1-WATER",
    "MAGNESIUMSTEARAAT (E 470b)",
    "MANNITOL (D-) (E 421)",
    "MAÏSZETMEEL",
    "POVIDON K 30 (E 1201)",
    "TRINATRIUMCITRAAT 2-WATER (E 331)"
  ],
  "substances": [
    "BUPRENORFINEHYDROCHLORIDE"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h132208.pdf",
  "authorised_at": "2025/04/14",
  "procedure_number": "SE/H/2385/001",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "132208",
  "additional_monitoring": "N"
}

See everything about buprenorphine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.